Clinical and pathologic features of familial pancreatic cancer
Open Access
- 14 October 2014
- Vol. 120 (23) , 3669-3675
Abstract
BACKGROUND: Inherited predisposition to pancreatic cancer contributes significantly to its incidence and presents an opportunity for the development of early detection strategies. The genetic basis of predisposition remains unexplained in a high proportion of patients with familial PC (FPC).METHODS: Clinicopathologic features were assessed in a cohort of 766 patients who had been diagnosed with pancreatic ductal adenocarcinoma (PC). Patients were classified with FPC if they had ≥1 affected first‐degree relatives; otherwise, they were classified with sporadic PC (SPC).RESULTS: The prevalence of FPC in this cohort was 8.9%. In FPC families with an affected parent‐child pair, 71% in the subsequent generation were 12.3 years younger at diagnosis. Patients with FPC had more first‐degree relatives who had an extrapancreatic malignancy (EPM) (42.6% vs 21.2; P<.0001), particularly melanoma and endometrial cancer, but not a personal history of EPM. Patients with SPC were more likely to be active smokers, have higher cumulative tobacco exposure, and have fewer multifocal precursor lesions, but these were not associated with differences in survival. Long‐standing diabetes mellitus (>2 years) was associated with poor survival in both groups.CONCLUSIONS: FPC represents 9% of PC, and the risk of malignancy in kindred does not appear to be confined to the pancreas. Patients with FPC have more precursor lesions and include fewer active smokers, but other clinicopathologic factors and outcome are similar to those in patients with SPC. Furthermore, some FPC kindreds may exhibit anticipation. A better understanding of the clinical features of PC will facilitate efforts to uncover novel susceptibility genes and the development of early detection strategies. Cancer 2014;120:3669–3675. © 2014 American Cancer Society.Keywords
Funding Information
- National Health and Medical Research Council (631701, 535903, 427601)
- Cancer Council NSW (SRP06-01)
- Cancer Institute NSW (06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-0)
- Gastroenterological Society of Australia (Clinica Research Scholarship (JH))
- Australian Cancer Research Foundation
- Royal Australasian College of Physicians
- Australian Government: Department of Innovation, Industry, Science and Research (DIISR)
- Avner Nahmani Pancreatic Cancer Foundation
- Philip Hemstritch Foundation
- Queensland Governement (NIRAP)
- Royal Australasian College of Surgeons (RACS)
- Royal College of Pathologists of Australasia (RCPA)
This publication has 35 references indexed in Scilit:
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancerGut, 2012
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- ATM Mutations in Patients with Hereditary Pancreatic CancerCancer Discovery, 2012
- Patterns of Pancreatic Resection Differ Between Patients with Familial and Sporadic Pancreatic CancerJournal of Gastrointestinal Surgery, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Pancreatic CancerNew England Journal of Medicine, 2010
- Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer PatientsClinical Cancer Research, 2009
- Epidemiology of pancreatic cancer: an overviewNature Reviews Gastroenterology & Hepatology, 2009
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility GeneScience, 2009
- Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1Gut, 2007